Medicus Pharma Ltd. (MDCX)
2.50
-0.12
(-4.58%)
USD |
NASDAQ |
Oct 23, 16:00
2.58
+0.08
(+3.20%)
After-Hours: 20:00
Medicus Pharma Enterprise Value : 155.00M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 155.00M |
| October 22, 2026 | 162.22M |
| October 21, 2026 | 165.83M |
| October 20, 2026 | 168.24M |
| October 19, 2026 | 164.33M |
| October 16, 2026 | 200.13M |
| October 15, 2026 | 210.96M |
| October 14, 2026 | 192.31M |
| October 13, 2026 | 201.93M |
| October 12, 2026 | 219.98M |
| October 09, 2026 | 281.66M |
| October 08, 2026 | 311.14M |
| October 07, 2026 | 486.53M |
| October 06, 2026 | 483.52M |
| October 05, 2026 | 506.99M |
| October 02, 2026 | 488.94M |
| October 01, 2026 | 476.90M |
| September 30, 2026 | 488.94M |
| September 29, 2026 | 475.70M |
| September 28, 2026 | 462.16M |
| September 25, 2026 | 463.06M |
| September 24, 2026 | 482.32M |
| September 23, 2026 | 484.12M |
| September 22, 2026 | 497.96M |
| September 21, 2026 | 519.02M |
| Date | Value |
|---|---|
| September 18, 2026 | 516.91M |
| September 17, 2026 | 517.82M |
| September 16, 2026 | 474.49M |
| September 15, 2026 | 462.16M |
| September 14, 2026 | 483.82M |
| September 11, 2026 | 493.75M |
| September 10, 2026 | 490.14M |
| September 09, 2026 | 517.21M |
| September 08, 2026 | 516.01M |
| September 04, 2026 | 522.03M |
| September 03, 2026 | 517.51M |
| September 02, 2026 | 786.47M |
| September 01, 2026 | 760.29M |
| August 31, 2026 | 792.18M |
| August 28, 2026 | 779.85M |
| August 27, 2026 | 810.23M |
| August 26, 2026 | 812.34M |
| August 25, 2026 | 789.78M |
| August 24, 2026 | 778.94M |
| August 21, 2026 | 822.27M |
| August 20, 2026 | 823.47M |
| August 19, 2026 | 800.30M |
| August 18, 2026 | 796.69M |
| August 17, 2026 | 786.77M |
| August 14, 2026 | 847.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals, Inc. | 1.862B |
| enGene Therapeutics, Inc. | -128.59M |
| Xenon Pharmaceuticals, Inc. | 2.495B |
| Psyence Biomedical Ltd. | -- |
| AVITA Medical, Inc. | 517.02M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.440M |
| Total Expenses (Quarterly) | 8.392M |
| EPS Diluted (Quarterly) | -0.1524 |
| Earnings Yield | -64.83% |
| Normalized Earnings Yield | -54.51 |